Atlas FDA

EXOGEN 4000+ BONE HEALING SYSTEM

FDA premarket approval P900009/S022 · decided 2006-06-26

Approval details

PMA number
P900009
Supplement
S022
Supplement type
Normal 180 Day Track
Supplement reason
Change Design/Components/Specifications/Material
Trade name
EXOGEN 4000+ BONE HEALING SYSTEM
Generic name
Stimulator, ultrasound and muscle, for use other than applying therapeutic deep
Applicant
Bioventus, LLC
Date received
2005-12-16
Decision date
2006-06-26
Days to decision
192 days
Decision code
APPR
Product code
LPQ
Advisory committee
Orthopedic
Expedited review
No
Location
Durham, NC
Statement
APPROVAL FOR THE MODIFICATION OF THE EXISTING EXOGEN 2000+ AND EXOGEN 3000 LOW INTENSITY ULTRASOUND FRACTURE TREATMENT SYSTEMS - SONIC ACCELERATED FRACTURE HEALING SYSTEM (SAFHS) TO THE EXOGEN 4000+. THE EXOGEN 4000+ IS MODIFIED TO INCORPORATE USER-INTERFACE MODIFICATIONS AND DESIGN MODIFICATIONS TO COMPENSATE FOR CHANGES IN ELECTRONIC COMPONENT AVAILABILITY. THE DEVICE, AS MODIFIED, WILL BE MARKETED UNDER THE TRADE NAME EXOGEN 4000+ BONE HEALING SYSTEM. THE EXOGEN 4000+ IS INDICATED FOR THE NON

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
StimTrial Neuromodulation System (K243782)Bioventus, LLC2025-07-16
TalisMann Neuromodulation System (K243678)Bioventus, LLC2025-07-03
Allograft Delivery Device (OFAC-C) (K233368)Bioventus, LLC2024-06-25
SIGNAFUSE Bioactive Strip (SBS); SIGNAFUSE Putty (K233490)Bioventus, LLC2023-12-05
MCS Bone Graft (K162860)Bioventus, LLC2017-02-13